Recash test site | Gammelgaard Kaspersen | Activity https://recash.wpsoul.net/members/openfaucet08/activity/ Activity feed for Gammelgaard Kaspersen. Sat, 25 Jul 2026 21:27:07 +0000 https://buddypress.org/?v= en-US 30 hourly 2 5e0bde2eb3f01b550fd57ae9ae7066b3 Gammelgaard Kaspersen posted an update: The aims of this study were to characterize the single-dose […] https://recash.wpsoul.net/activity/p/133673/ Wed, 01 Jan 2025 09:29:26 +0000 The aims of this study were to characterize the single-dose pharmacokinetics (PK) of the major active metabolites of ozanimod, CC112273 and CC1084037, and to evaluate the effect of gemfibrozil (a strong inhibitor of cytochrome P450 [CYP] 2C8), itraconazole (a strong inhibitor of CYP3A and P-glycoprotein [P-gp]), and rifampin (a strong inducer of…[Read more]

]]> 0 9e8206690187b09bbc29dd483265ff05 Gammelgaard Kaspersen became a registered member https://recash.wpsoul.net/activity/p/90849/ Fri, 20 Dec 2024 08:59:32 +0000 0